Niagen Bioscience (NAGE) Interest Expenses (2010 - 2022)
Niagen Bioscience (NAGE) posted quarterly Interest Expenses of $421000.0 for Q1 2026, down 89.55% year-over-year from $4.0 million in Q1 2025, and up 166.19% quarter-over-quarter from -$636000.0 in Q4 2025.
Powered by 
Analysis
Niagen Bioscience (NAGE) Interest Expenses (2010 - 2022) Analysis & Trends
Niagen Bioscience (NAGE) has reported Interest Expenses for 17 consecutive years, with $421000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses fell 89.55% year-over-year to $421000.0; the TTM figure through Mar 2026 stood at $421000.0 (down 89.55% YoY), while the FY2025 annual figure was $40.5 million, down 8.58% from the prior year.
- Interest Expenses improved to $421000.0 in Q1 2026 per NAGE's latest filing, from -$636000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $5.3 million in Q2 2022 and bottomed at -$636000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $2.2 million across 5 years, with a median of $657000.0 in 2025.
- On a YoY basis, Interest Expenses climbed as much as 1482.11% in 2025 and fell as far as 362.81% in 2025.
- Niagen Bioscience's Interest Expenses stood at $135000.0 in 2022, then slipped by 24.44% to $102000.0 in 2023, then surged by 137.25% to $242000.0 in 2024, then plunged by 362.81% to -$636000.0 in 2025, then surged by 166.19% to $421000.0 in 2026.
- Business Quant data shows NAGE's Interest Expenses at $421000.0 in Q1 2026, -$636000.0 in Q4 2025, and $657000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Niagen Bioscience | 251.05 Mn | 184.31 Mn | 19.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | 15,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 16,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | 24,000.00 |
| Dec 31, 2019 | -7,000.00 |
| Sep 30, 2019 | 314,000.00 |
| Jun 30, 2019 | 575,000.00 |
| Dec 31, 2018 | -22,000.00 |
| Sep 30, 2018 | 9,000.00 |
| Jun 30, 2018 | 65,000.00 |
| Mar 31, 2018 | 44,000.00 |
| Sep 30, 2017 | 45,000.00 |
| Jul 1, 2017 | 746,000.00 |
| Apr 1, 2017 | 28,000.00 |